FRANCK BELIBI: Open Payments
NPI 1831211069 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 6 companies in 2025. Trend: 2023 $389 · 2024 $321 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $87 |
| Amgen Inc. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Novo Nordisk Inc | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: XIFAXAN, KRYSTEXXA, Ozempic, BREZTRI, JYNARQUE, GVOKE HYPOPEN.
Industry payments across CO — which companies pay providers there.
